Early detection of cardiac involvement in thalassemia: From bench to bedside perspective

Nut Koonrungsesomboon1, Siriporn C Chattipakorn, Suthat Fucharoen

  • 1Nut Koonrungsesomboon, Siriporn C Chattipakorn, Nipon Chattipakorn, Cardiac Electrophysiology Research and Training Center, Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.

World Journal of Cardiology
|September 7, 2013
PubMed

Insights

Myocardial siderosis in thalassemia major (TM) patients leads to fatal iron overload cardiomyopathy. Early detection via cardiac MRI and heart rate variability is crucial for preventing mortality in these patients.

Area of Science:

  • Cardiology
  • Hematology
  • Medical Imaging

Background:

  • Myocardial siderosis is a primary cause of death in thalassemia major (TM) patients, leading to iron overload cardiomyopathy.
  • Despite chelation therapy, high mortality persists due to delayed detection of cardiac iron overload.
  • Current iron assessment methods have limitations and controversial evidence in clinical practice.

Purpose of the Study:

  • To comprehensively review and present all proposed methods for assessing cardiac iron status in TM patients.
  • To discuss the efficacy and limitations of various direct and indirect iron assessment techniques.
  • To highlight cardiac magnetic resonance imaging and heart rate variability for early detection.

Main Methods:

  • Systematic review of basic and clinical studies on cardiac iron assessment in TM.
  • Analysis of direct and indirect iron assessment methods: serum ferritin, echocardiogram, non-transferrin-bound iron, cardiac MRI T2*, heart rate variability, biopsies.
  • Focused discussion on cardiac MRI and heart rate variability for early detection.

Main Results:

  • Various methods exist for assessing cardiac iron overload, but clinical application is limited by controversy and evidence gaps.
  • Cardiac magnetic resonance imaging (cardiac MRI) and heart rate variability (HRV) show promise for early detection of cardiac involvement.
  • The review synthesizes existing data on these methods, addressing controversies in cardiac assessment for TM.

Conclusions:

  • Early and accurate detection of cardiac iron overload is critical for improving survival in TM patients.
  • Cardiac MRI and heart rate variability are emerging as valuable tools for the early diagnosis of cardiac complications in TM.
  • Further research and standardization are needed to address controversies and optimize clinical use of these assessment methods.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...